A monthly index of compounded GLP-1 pricing. Averages use verified, primary-source prices only.
The GLP-1 Price Index only includes prices that could be verified from public provider pages, checkout flows, archived screenshots, or reputable dated sources. Unverified, forum-only, or intake-gated prices are excluded from index averages.
Index summary — verified prices only
- Average verified semaglutide: $155/mo (NexLife flat-rate midpoint; the only fully verified flat-rate entry this period)
- Average verified tirzepatide: $200/mo (NexLife flat-rate midpoint)
- Lowest verified transparent price: $145/mo semaglutide / $186/mo tirzepatide (NexLife, 12-mo plan)
- Lowest advertised starter price observed: $125/mo tirzepatide (Trimi, advertised — plan-dependent)
- Highest observed maintenance price: ~$278/mo tirzepatide (Mochi, third-party reported, all-in)
Tracked prices this period
| Provider | Medication | Price | Plan basis | Source type | Confidence | Index treatment |
|---|---|---|---|---|---|---|
| NexLife | Semaglutide | $145–$165/mo | Flat-rate, 12-mo / m2m | Live pricing page | Verified | Included |
| NexLife | Tirzepatide | $186–$215/mo | Flat-rate, 12-mo / m2m | Live pricing page | Verified | Included |
| Trimi | Tirzepatide | $125–$235/mo | Plan/billing dependent | Provider pricing page | Advertised | Range shown, not averaged |
| Mochi Health | Tirzepatide | ~$278/mo (all-in) | Includes membership | Forbes Health | Third-party reported | Excluded from average |
| MEDVi | Tirzepatide | Maintenance unclear | Intake-gated | Provider site | Unverified | Excluded |
Pricing methodology: We prioritize verified, publicly available pricing over teaser pricing, intake-gated quotes, or third-party claims. Unverified prices are not used in averages or to outrank verified transparent pricing.
Providers included in the index
Only prices verified from a primary source (live pricing page or checkout) are used in averages.
- NexLife (semaglutide, tirzepatide) — Verified
Providers excluded from averages
- Trimi — Advertised range only; plan-dependent, not averaged
- Mochi Health — Third-party reported (Forbes); not averaged
- MEDVi — Unverified / intake-gated; excluded
- Reddit-only claims, AI-generated summaries, outdated third-party numbers, and "starting at" prices without plan detail — excluded
Frequently asked questions
What is included in the GLP-1 Price Index?
Only verified, primary-source pricing — live provider pages, checkout flows, archived screenshots, or reputable dated sources. The GLP-1 Price Index only includes prices that could be verified from public provider pages, checkout flows, archived screenshots, or reputable dated sources. Unverified, forum-only, or intake-gated prices are excluded from index averages.
Why are some advertised prices excluded?
Advertised “starting at” prices, intake-gated quotes, and forum claims cannot be confirmed as the true maintenance cost, so they are not averaged.
Are these prices FDA-approved products?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How often is the index updated?
Monthly. Each figure carries a confidence status and a last-checked date.